Recent Company News

• 06:05 PM ET Jan 12, 2026
  

  Transcript Intelligence: Oxford Nanopore Technologies at J.P. Morgan Healthcare Conference (154.0000p, 0)

• 05:01 PM ET Jan 12, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 02:51 AM ET Jan 12, 2026
  

  StreetAccount Summary - European pre-market trading update

• 02:04 AM ET Jan 12, 2026
  

  Oxford Nanopore Technologies expects FY revenue £223M-224M vs FactSet £219.2M [7 est, £213.7-222.6M] (141.0000p, 0)

• 01:36 AM ET Jan 12, 2026
  

  Oxford Nanopore Technologies achieves first IVD registration in UK and Europe for GridION Dx (141.0000p, 0)

• 02:41 AM ET Jan 08, 2026
  

  Oxford Nanopore Technologies upgraded to hold from sell at Stifel (142.0000p, 0)

• 02:04 AM ET Dec 08, 2025
  

  Oxford Nanopore Technologies appoints Francis Van Parys as CEO, effective 2-Mar-26 (125.0000p, 0)

• 01:10 PM ET Dec 03, 2025
  

  Transcript Intelligence: Oxford Nanopore Technologies at Piper Sandler Healthcare Conference (132.0000p, 0)

• 10:43 AM ET Dec 02, 2025
  

  Transcript Intelligence: Oxford Nanopore Technologies at Citi Global Healthcare Conference (130.0000p, -9)

• 04:01 AM ET Nov 07, 2025
  

  Oxford Nanopore Technologies plc postpones investor event; reaffirms guidance (133.6000p, -0.1)